Jean Bizzari
Director/Board Member presso ADC THERAPEUTICS SA
Patrimonio netto: 3 M $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Bernd Seizinger | M | 67 |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | 9 anni |
| Thomas Bures | M | 49 | 7 anni | |
| Jeffrey Henderson | M | 59 | 9 anni | |
| Christian Rohlff | M | 62 |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | 21 anni |
| Mark Snyder | M | 57 | 2 anni | |
| Marc Buyse | M | - |
International Drug Development Institute SA
 International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | 36 anni |
| Richard Peters | M | 61 | 4 anni | |
| Ameet Mallik | M | 51 | 2 anni | |
| Oren Gilad | M | 56 | 2 anni | |
| John Hamill | M | 60 | 1 anni | |
| James Geraghty | M | 70 | 7 anni | |
| Tram Bui | F | - | 2 anni | |
| Viviane Monges | F | 60 | 3 anni | |
| Rifat Pamukcu | M | 66 | 2 anni | |
| Damien Tremolet | M | - |
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | - |
| Henri Tassenoy | M | - |
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | - |
| Michael Grissinger | M | 70 | 2 anni | |
| Ann Barbier | M | 59 | 6 anni | |
| John Henneman | M | 62 | 5 anni | |
| Christopher Kiritsy | M | 59 | 8 anni | |
| Eran Ben-Dor | M | - | 5 anni | |
| Gabriela Gruia | M | 67 | 1 anni | |
| Mathias Hukkelhoven | M | 70 | 2 anni | |
| Yvonne Naughton | M | - | 3 anni | |
| Patrick Mehlen | M | - |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | 16 anni |
| Agnès Bernet | M | - |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | 16 anni |
| Peter Kiener | M | 72 | 6 anni | |
| Tyrell J. Rivers | M | 51 | 6 anni | |
| Thomas Pfisterer | M | 42 | 8 anni | |
| Barbara Duncan | F | 59 | 1 anni | |
| Bernadette Connaughton | F | 65 | 6 anni | |
| Akiko Miyashita | F | 68 | 2 anni | |
| Peter Hug | M | 65 | 5 anni | |
| Victor Sandor | M | 57 | 4 anni | |
| Maya Said | M | 47 | 5 anni | |
| Marc Duey | M | 68 | 2 anni | |
| Matthew Sherman | M | 68 | 6 anni | |
| Zeev Weiss | M | 62 | 2 anni | |
| Mohamed Zaki | M | 59 | 1 anni | |
| Ron Squarer | M | 57 | 4 anni | |
| Jason Gould | M | 55 |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | - |
| Kayti Aviano | F | - | 7 anni | |
| Steve Knowles | M | - | 6 anni | |
| Diego du Monceau de Bergendal | M | 75 |
European Organisation for Research & Treatment of Cancer
| - |
| Christophe Guichard | M | 55 |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | 11 anni |
| Linda Danielson | F | - |
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | 18 anni |
| Hitto Kaufmann | M | 53 | 5 anni | |
| Amy Marinne Fox | F | - | 4 anni | |
| Marc Melviez | M | - |
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | - |
| Patrick van Berkel | M | 55 | 12 anni | |
| Kimberly Pope | F | 57 | 4 anni | |
| Victoria Billecocq | F | - |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | 3 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 69 | 69.00% |
| Svizzera | 16 | 16.00% |
| Belgio | 6 | 6.00% |
| Israele | 5 | 5.00% |
| Francia | 4 | 4.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Jean Bizzari
- Contatti personali
